The abstract is read at the publisher; the summary is JClub's.
In a French nationwide ICU cohort, influenza A(H3N2) subclade K emerged in 82.5% of sequenced A(H3N2) cases, yet day-28 mortality risk was not increased in 2025–2026.
- Why it matters: Despite reports of intense influenza activity and mixed public-health signals, clinicians lacked ICU-level evidence on whether the rise of A(H3N2) subclade K shifts clinical severity.
- What they did: The SEVARVIR prospective multicenter observational study enrolled 726 laboratory-confirmed ICU admissions across 42 French ICUs in 2024–2025 (n=360) and 2025–2026 (n=366), with day-28 mortality as the primary endpoint.
- The result: In 2025–2026, age, Clinical Frailty Scale, and sequential organ failure assessment score predicted higher day-28 death risk, while influenza subtype was not linked to significant mortality, and phylogenetics showed no severity clustering.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.